Skip to main content
. 2017 Sep 29;7(9):e017296. doi: 10.1136/bmjopen-2017-017296

Table 1.

Exposure and outcome measures at each data collection time point

Variable group Measures Source of measures
A IPV exposure Ever physical, sexual, emotional
Past year, postrape
WHO multi-country study instrument61 (tested in South Africa by Jewkes et al)62
B Rape circumstances and physical trauma/injuries Rape circumstances: number of perpetrators, relationship to perpetrator, weapon use, degree of violence, type of rape
Intimidation by the perpetrator or friends
Jewkes et al63
(Questions to be asked after criminal case have been closed)
C Rape stigma and social support Rape stigma and self-blame
Coping mechanisms
Rape disclosure
Social support
Social disruption: leaving home, school, relationship
Social Support Appraisal Scale64; Brief COPE65;
South African Stigma Scale66
D Demographic factors Demographic factors: age, income, education, employment, relationship status, sexual orientation Jewkes et al62
E Mental health outcomes Depression
Anxiety disorders
PTSD
Suicidality
Other anxiety disorders
Alcohol and drug abuse
Cortisol level in hair
Epigenetic changes
Telomere length
MINI for psychosis and anxiety disorders49; CES-D (depression)67; AUDIT (alcohol)68; DUDIT (drugs)68–70; Life Events Checklist71; Davidson Trauma Scale (PTSD)72 73
Cortisol in hair and epigenetics analysis from blood samples
F Other trauma Previous trauma: child abuse, other interpersonal violence or traumatic life events
Follow-up interview: rape, interpersonal violence or traumatic life events since the last interview
Childhood trauma scale Bernstein et al74 modified for South Africa Jewkes et al75
Life Events Checklist; rape and forced sex measures from Jewkes et al62
G Criminal justice processes and circumstances of the rape Case progression: case dropped, arrest, bail, guilty plea, case withdrawn, trial commenced, testimony in court given, trial outcome
Perceived satisfaction with the system including information given about whereabouts of accused
Jewkes et al63; satisfaction questions to be developed
(These questions will be asked once criminal case have been closed.)
H Acquiescence to male domination of sex Attitudes to gender relations and perceived social norms
Consistent condom use
Relationship control scale
Sexual frequency
Jewkes et al62; attitudes developed in South Africa and validated in Jewkes et al76
I Own sexual risk behaviour Transactional sex
Partner numbers ever and past year
Concurrency
Jewkes et al62  75
J Partner riskiness STIs of current partner
Use of IPV by current partner
Partners’ concurrency/polygamy
Jewkes et al62 4
K Biological risk enhancers or co-factors Hormonal contraception use at baseline and ongoing
Pregnancy loss (since last interview): termination, miscarriage
Questions from the Demographic and Health Survey77
L Cardio-metabolic risk assessment Screening questions for risk assessment
Measurements: hip and waist, BP, BMI, glucose status (glycaemia/Hba1c) and lipid panels
CRP ultrasensitive (cardiac), Gamma-GT, ALT (SGPT), AST (SGOT), creatinine (serum),
Questions from the WHO STEPs questionnaire78
M Healthcare seeking practices postrape health, HIV testing and adherence Completion of PEP and STI treatment
Emergency contraception
HIV testing postrape and previously
HIV disclosure
Attendance for health assessment
Commencement of ART and adherence
Experience of HIV-related ill-health
Satisfaction with healthcare provision
Items developed and tested in pilot
O Reproductive and child health Contraception, fertility, pregnancies, reproductive health
Child health including babies born during RICE study participation
Questions developed and adapted from Demographic and Health Survey

ALT, alanine aminotransferase; ART, antiretroviral therapy; AST, aspartate aminotransferase; AUDIT, Alcohol Use Disorders Identification Test; BMI, body mass index; BP, blood pressure; CES-D, Center for Epidemiologic Studies Depression Scale; CRP, C-reactive protein; DUDIT, Drug Use Disorders Identification Test; IPV, intimate partner violence; MINI, Mini International Neuropsychiatric Interview; PEP, postexposure prophylaxis; PTSD, post-traumatic stress disorder; RICE, Rape Impact Cohort Evaluation; SGOT, serum glutamic oxaloacetic transaminase; SGPT, serum glutamic pyruvic transaminase; STI, sexually transmitted infection.